Abstract
Acutely psychotic schizophrenic patients were maintained on debrisoquin (DBQ) throughout 5 weeks of treatment with haloperidol. Treatment with haloperidol caused initial increases in urinary homovanillic acid (HVA) output that returned toward baseline by the 5th week. During haloperidol treatment, plasma levels of HVA tended to decrease, concurrent with increased renal clearance of HVA. Plasma 3-methoxy-4-hydroxyphenyl-glycol (MHPG) levels and urinary MHPG output both decreased over the course of treatment. The differences in HVA and MHPG metabolism suggest differential effects of treatment on dopamine and norepinephrine systems. Neuroleptic treatment also abolished the marked morning decreases in plasma HVA concentrations (reported in part I).
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Address reprint requests to: James W. Maas, M.D., Department of Psychiatry, The University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, Texas, 78284-7792.
Rights and permissions
About this article
Cite this article
Maas, J., Contreras, S., Miller, A. et al. Studies of Catecholamine Metabolism in Schizophrenia/Psychosis-II. Neuropsychopharmacol 8, 111–116 (1993). https://doi.org/10.1038/npp.1993.12
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/npp.1993.12